Challenged by ongoing COVID-19 threats, particularly among older adults, healthcare systems need to maintain vigilance via disease surveillance and vaccination efforts, according to the latest study published by the JAMA Internal Medicine. The study cites alarming statistics demonstrating the disproportionate impact of COVID-19 on the elderly population. Between 2023 and 2024, for example, while older…
The Centers for Disease Control and Prevention (CDC) has refreshed its guidelines surrounding the vaccination of Respiratory Syncytial Virus (RSV) for older adults. This significant update primarily affects adults who are within the 60-74 age bracket with an elevated risk for RSV. In addition to this, all individuals aged 75 and over are now recommended…